SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-043469
Filing Date
2021-08-11
Accepted
2021-08-11 16:31:31
Documents
50
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q life-10q_20210630.htm   iXBRL 10-Q 2387859
2 EX-31.1 life-ex311_8.htm EX-31.1 9627
3 EX-31.2 life-ex312_6.htm EX-31.2 9123
4 EX-32.1 life-ex321_7.htm EX-32.1 5502
5 EX-32.2 life-ex322_9.htm EX-32.2 5491
  Complete submission text file 0001564590-21-043469.txt   7042939

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA life-20210630.xsd EX-101.SCH 40590
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE life-20210630_cal.xml EX-101.CAL 42352
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE life-20210630_def.xml EX-101.DEF 142563
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE life-20210630_lab.xml EX-101.LAB 331266
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE life-20210630_pre.xml EX-101.PRE 244936
11 EXTRACTED XBRL INSTANCE DOCUMENT life-10q_20210630_htm.xml XML 1252131
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37378 | Film No.: 211163867
SIC: 2836 Biological Products, (No Diagnostic Substances)